title: Simultaneous separation of 14 antiarrhythmic drugs and determination of mexiletine and flecainide by capillary zone electrophoresis.
abstract: A method using capillary zone electrophoresis was developed for the simultaneous separation of 14 antiarrhythmic drugs belonging to various classes. The drugs are separated on a fused-silica capillary, 90 cm x 75 microm (72 cm effective length), with phosphate and acetate buffers as background electrolytes and UV detection at 217 nm. The effects of buffer pH, temperature, and applied voltage on the migration of the drugs were studied. The pH was found to be the most significant factor determining effective separation. The antiarrhythmic compounds are completely separated within a relatively short time (< 7 min) by using 70 mM phosphate buffer at pH 7.91, an applied voltage of 28 kV, and a temperature of 32 degrees C. Mexiletine (MEX) and flecainide (FLE) were quantified under conditions of the optimum separation. The calibration graphs were constructed over the concentration range of 4.0-14.0 microg/mL for both drugs with good correlation (r > or = 0.9999). Detection and quantitation limits were found to be 0.5 and 1.5 microg/mL for FLE and 0.7 and 2.1 microg/mL for MEX, respectively. The proposed method was used for the determination of both drugs in their commercial forms with satisfactory precision (relative standard deviations of 0.36-1.21% for FLE and 0.78-1.66% for MEX) and accuracy (relative standard errors of 0.13-1.17% for FLE and 0.35-1.18% for MEX).
authors.affiliation: Medical University of Lublin, Department of Medicinal Chemistry, 4 Jaczewskiego Str, 20090 Lublin, Poland. rafal.pietras@am.lublin.pl
authors.forename: Rafał
authors.initials: R
authors.lastname: Pietraś
authors.forename: Dorota
authors.initials: D
authors.lastname: Kowalczuk
authors.forename: Hanna
authors.initials: H
authors.lastname: Hopkała
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D002138:Calibration; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D015195:Drug Design; D004573:Electrolytes; D019075:Electrophoresis, Capillary / Q000379:methods*; D005424:Flecainide / Q000032:analysis* / Q000302:isolation & purification; D006863:Hydrogen-Ion Concentration; D008801:Mexiletine / Q000032:analysis* / Q000302:isolation & purification; D010710:Phosphates / Q000737:chemistry; D012044:Regression Analysis; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet; D013696:Temperature
chemical_list: D000889:Anti-Arrhythmia Agents; D004573:Electrolytes; D010710:Phosphates; D008801:Mexiletine; D005424:Flecainide